Predictors and outcomes of completion axillary node dissection among older breast cancer patients

Annals of Surgical Oncology

Volumn 21, Issue 7, 2014, Pages 2172-2180

  Javid, Sara H ^a   He, Hao ^a   Korde, Larissa A ^a   Flum, David R ^a   Anderson, Benjamin O ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR;

AGED; ARTICLE; AXILLARY LYMPH NODE; AXILLARY LYMPH NODE EXTIRPATION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER REGISTRY; CANCER SIZE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CAUSE SPECIFIC SURVIVAL; COMORBIDITY; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL RECORD; SENTINEL LYMPH NODE BIOPSY; AXILLA; BREAST NEOPLASMS; CANCER GRADING; COHORT ANALYSIS; FOLLOW UP; MORTALITY; OUTCOME ASSESSMENT; PATHOLOGY; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; NEOPLASM GRADING; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); SEER PROGRAM; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;

EID: 84902190504     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3595-8     Document Type: Article

References (28)

1. MMWR. From the Centers for Disease Control and Prevention Public Health and aging: trends in aging - United States and worldwide. JAMA. 2003;289:1371-3.
2. Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341:2061-7.
3. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med. 1998;339:941-6.
4. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222:394-9.
5. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546-53.
6. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006;13:491-500.
7. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569-75.
8. Karam AK, Hsu M, Patil S, et al. Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodes. Ann Surg Oncol. 2009;16:1952-8.
9. Truong PT, Bernstein V, Wai E, et al. Age-related variations in the use of axillary dissection: a survival analysis of 8038 women with T1-T2 breast cancer. Int J Radiat Oncol Biol Phys. 2002;54:794-803.
10. Aziz D, Gardner S, Pritchard K, et al. Selective application of axillary node dissection in elderly women with early breast cancer. Ann Surg Oncol. 2007;14:652-9.
11. Reeder-Hayes KE, Bainbridge J, Meyer AM, et al. Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer. Breast Cancer Res Treat. 2011;128:863-71.
12. Rescigno J, Zampell JC, Axelrod D. Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy. Ann Surg Oncol. 2009;16:687-96.
13. Maggard MA, Lane KE, O'Connell JB, et al. Beyond the clinical trials: how often is sentinel lymph node dissection performed for breast cancer? Ann Surg Oncol. 2005;12:41-7.
14. Chen AY, Halpern MT, Schrag NM, et al. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005). J Natl Cancer Inst. 2008;100:462-74.
15. Halpern MT, Chen AY, Marlow NS, et al. Disparities in receipt of lymph node biopsy among early-stage female breast cancer patients. Ann Surg Oncol. 2009;16:562-70.
16. Edge SB, Gold K, Berg CD, et al. Patient and provider characteristics that affect the use of axillary dissection in older women with stage I-II breast carcinoma. Outcomes and Preferences for Treatment in Older Women Nationwide Study Research Team. Cancer. 2002;94:2534-41.
17. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8 Suppl):IV-3-18.
18. Enger SM, Thwin SS, Buist DS, et al. Breast cancer treatment of older women in integrated health care settings. J Clin Oncol. 2006;24:4377-83.
19. Ballard-Barbash R, Potosky AL, Harlan LC, et al. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst. 1996;88:716-26.
20. Silliman RA, Troyan SL, Guadagnoli E, et al. The impact of age, marital status, and physician-patient interactions on the care of older women with breast cancer. Cancer. 1997;80:1326-34.
21. Hebert-Croteau N, Brisson J, Latreille J, et al. Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer. 1999;85:104-13.
22. Mandelblatt JS, Hadley J, Kerner JF, et al. Patterns of breast carcinoma treatment in older women: Patient preference and clinical and physician influences. Cancer. 2000;89:561-73.
23. Martelli G, Boracchi P, Ardoino I, et al. Axillary dissection versus no axillary dissection in older patients with T1N0 breast cancer: 15-year results of a randomized controlled trial. Ann Surg. 2012;256:920-4.
24. Näslund E, Fernstad R, Ekman S, et al. Breast cancer in women over 75 years: is axillary dissection always necessary? Eur J Surg. 1996;162:867-71.
25. Dees EC, Shulman LN, Souba WW, et al: Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection. Ann Surg. 1997;226:279-86.
26. Feigelson BJ, Acosta JA, Feigelson HS, et al. T1 breast carcinoma in women 70 years of age and older may not require axillary lymph node dissection. Am J Surg. 1996;172:487-9.
27. Muss HB, Woolf S, Berry D, et al. Cancer and Leukemia Group B: Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA. 2005;293:1073-81.
28. Commission on Cancer National Cancer Data Base (NCDB). Coding Cancer Registry Items. 2012. http://www.facs.org/cancer/ncdb/scope-regional-lymph-node- surgery.pdf. Accessed 1 Dec 2013.